Filing Details
- Accession Number:
- 0001179110-18-001372
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-01 17:47:03
- Reporting Period:
- 2018-01-30
- Accepted Time:
- 2018-02-01 17:47:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1612571 | B Robert Ford | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2018-01-30 | 4,467 | $26.19 | 56,633 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2018-01-30 | 10,400 | $22.39 | 67,033 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2018-01-30 | 19,600 | $27.03 | 86,633 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2018-01-30 | 49,000 | $34.94 | 135,633 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.81 | 135,433 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 300 | $62.82 | 135,133 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 100 | $62.83 | 135,033 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 527 | $62.83 | 134,506 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 100 | $62.84 | 134,406 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.85 | 134,206 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 100 | $62.85 | 134,106 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 100 | $62.86 | 134,006 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 400 | $62.88 | 133,606 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.89 | 133,406 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.90 | 133,206 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 100 | $62.90 | 133,106 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.91 | 132,906 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.93 | 132,706 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 1,100 | $62.95 | 131,606 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.96 | 131,406 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 2,700 | $62.96 | 128,706 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 200 | $62.97 | 128,506 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 2,000 | $62.97 | 126,506 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 400 | $62.98 | 126,106 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 1,000 | $62.98 | 125,106 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 1,346 | $62.99 | 123,760 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 100 | $62.99 | 123,660 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 3,600 | $62.99 | 120,060 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 5,303 | $63.00 | 114,757 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2018-01-30 | 21,789 | $63.00 | 92,968 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2018-01-30 | 4,467 | $0.00 | 4,467 | $26.19 |
Common Shares | Option (right to buy) | Disposition | 2018-01-30 | 10,400 | $0.00 | 10,400 | $22.39 |
Common Shares | Option (right to buy) | Disposition | 2018-01-30 | 19,600 | $0.00 | 19,600 | $27.03 |
Common Shares | Option (right to buy) | Disposition | 2018-01-30 | 49,000 | $0.00 | 49,000 | $34.94 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-02-19 | 2020-02-18 | No | 4 | M | Direct |
0 | 2014-02-18 | 2021-02-17 | No | 4 | M | Direct |
0 | 2015-02-17 | 2022-02-16 | No | 4 | M | Direct |
0 | 2016-02-15 | 2023-02-14 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.